-
EC Factsheet
Content Preview
Emergency contraception (EC) reduces the risk of unintended pregnancy after unprotected sexual intercourse. It can also be used when contraception may have failed, eg broken condom, missed pill and after sexual assault.
Please find relevant resources below:
EC Factsheet
Content Preview
Emergency contraception (EC) reduces the risk of unintended pregnancy after unprotected sexual intercourse. It can also be used when contraception may have failed, eg broken condom, missed pill and after sexual assault.
Contraceptive Choices factsheet
Content Preview
Contraception means prevention of pregnancy. There are a number of different methods and it is important to choose one that best meets your needs and circumstances.
210812_IUD_National_Standards_Final
Content Preview
The purpose of the standards is to outline the minimum clinical competencies required for both inserters and non-inserters of IUDs in Australia. Inserters will need to meet Parts A and B of the outlined competencies, and non-inserters who are dealing with women wanting IUDs in clinical practice will need only Part A of the competencies.
Time for a national sexual & reproductive health strategy call to action (2008)
Content Preview
Sexual and reproductive health is a human right recognised in several international agreements ratified by the Australian Government. In 2000, the Commonwealth Department of Health and Aged Care published a report which recommended the development of a comprehensive national sexual health strategy
Reproductive and Sexual Health Forum Summary report 2014
Content Preview
Family Planning NSW (FPNSW), in collaboration with Sexual Health and Family Planning Australia (SH&FPA), has been commissioned by the Commonwealth Department of Health to build and consolidate alliances with reproductive and sexual health researchers through holding two national research forums with associated preparation and follow up activities.
Research Forum Sexual health Summary Report 2016 06 15
Content Preview
Following the success of the National Reproductive Health Research Forum in May 2014, the National Sexual Health Research Forum was held on 13 November, 2015. The Forum was organised by Family Planning NSW on behalf of Family Planning Alliance Australia, who were commissioned by the Australian Government Department of Health, under the Family Planning Grants Program, to hold two national research forums.
Reproductive and Sexual Health in Australia (19Mb)
Content Preview
Reproductive and sexual health is a fundamental human right. Poor reproductive and sexual health is linked to poverty and a plethora of poor health outcomes. Within Australia there are a range of current and emerging reproductive and sexual health issues that require assessment and analysis.
FPAA Schools Education Position Statement
Content Preview
Family Planning Alliance Australia (FPAA) is the nation's peak body in reproductive and sexual health. The alliance advocates and drives improvement in public health by examining up-to-date evidence and representing leading health and education agencies across Australia.
FPAA Reproductive Coercion Position Paper Final September 2018
Content Preview
Access to and information about reproductive autonomy (including abortion) in Australia varies across states and territories. This variation can present a significant hurdle for women in situations of reproductive coercion seeking to regain reproductive autonomy and to maintain their reproductive and sexual health.
Use of non-sterile gloves for insertion of the Contraceptive Implant
Content Preview
Non sterile gloves can be used for those experienced with insertion of the contraceptive implant, who are confident with their no touch technique. Sterile gloves are recommended where there is a higher risk of skin infection, e.g. severe eczema or immunosuppression
Ulipristal Acetate Emergency Contraception and Breastfeeding
Content Preview
Ulipristal acetate emergency contraception (UPA EC) is administered as a single 30 mg oral dose within 5 days of unprotected intercourse. The Product Information and some contraceptive guidelines recommend expressing and discarding breastmilk for 7 days after administration. (1, 2) However, other guidelines recommend a 24 hour time frame, based on the rapidly declining levels of UPA excreted in breast milk 24 hours after a 30 mg dose.
Repeat dosing of oral hormonal contraceptives after vomiting
Content Preview
Vomiting after administration of an oral hormonal contraceptive or emergency contraceptive pill can result in a loss of effectiveness and a repeat dose may be required. The need for a repeat dose following vomiting is related to the time to absorption of the hormonal constituents in the small intestine: ethinylestradiol/ estradiol and progestogens in the combined pill; progestogens (levonorgestrel or norethisterone) in the progestogen only pill; levonorgestrel or ulipristal acetate in emergency contraceptive pills.
LGBTIQA people and communities
Content Preview
Family Planning Alliance Australia (FPAA) is a national peak body in reproductive and sexual health. FPAA promote advances in public health through policy insight and advocacy, and represent leading health and education agencies across Australia. FPAA recognises that compared to the general population, lesbian, gay, bisexual, transgender, intersex, queer or asexual (LGBTIQA) people in Australia experience poorer levels of health and wellbeing across a range of health indicators.
IUD and cervical cleansing
Content Preview
Evidence is lacking to support the use of antiseptics to cleanse the cervix prior to IUD insertion. Excessive debris such as mucus can be removed from the cervix or vulva with sterile cotton balls or gauze soaked in saline as an alternative to antiseptic. Sexually transmitted infections (STI) are not affected by standard antiseptics used to cleanse the cervix.
Drug interactions topiramate
Content Preview
Topiramate is a liver enzyme inducing medication.(1) There is limited information available on interactions between topiramate and hormonal contraception. Two studies have investigated the effect of topiramate on a combined oral contraceptive containing 35mcg of ethinyl estradiol and 1 mg norethisterone.
Drug interactions griseofulvin
Content Preview
Griseofulvin is not known to be a liver enzyme inducing medication, however there have been case reports of contraceptive failure and menstrual disturbance when it has been used in those taking combined hormonal contraceptives (1-3). Although there is insufficient evidence to say whether griseofulvin is teratogenic in humans it is known to be teratogenic in rats at 3-45 times the human dose and is classified as B3 for use in pregnancy.
4 day pill break FPAA
Content Preview
Currently the majority of Combined Oral Contraceptive (COCs) in Australia, including all COCs listed on the pharmaceutical benefits scheme (PBS), are dispensed in packaging which supplies 21 days of active hormone pills and 7 days of inactive pills (known as the hormone-free interval).
AHHA - A Health System That Supports Contraceptive Choice
Content Preview
Unplanned pregnancy is a key health issue for women in Australia. There has been increasing recognition, nationally and internationally, that a key way to reduce unintended pregnancy is to use more effective and less userâ€dependent methods of contraception such as the longâ€acting reversible contraceptive (LARC) methods. Despite evidence for the effectiveness of, and satisfaction with LARC methods, e.g. intrauterine devices and contraceptive implants, as well as support for their use by peak bodies and key opinion leaders in Australia and internationally, use of LARC methods in Australia continues to remain low.